Telix Pharmaceuticals (ASX:TLX) reported a robust 53% increase in Q3 revenue, driving optimism, though an FDA request for additional data on a kidney cancer diagnostic introduced some caution in ...
Gozellix is now a fully reimbursed product in the U.S., having been granted a Level II HCPCS code 14 and TPT payment status (effective 1 October 2025) 15. Telix is the only company with two U.S. Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback